Annual Accounts Receivable
$42.36 M
+$2.54 M+6.39%
December 31, 2023
Summary
- As of February 10, 2025, TOIIW annual accounts receivable is $42.36 million, with the most recent change of +$2.54 million (+6.39%) on December 31, 2023.
- During the last 3 years, TOIIW annual accounts receivable has risen by +$25.21 million (+147.05%).
- TOIIW annual accounts receivable is now at all-time high.
Performance
TOIIW Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$54.50 M
+$485.00 K+0.90%
September 30, 2024
Summary
- As of February 10, 2025, TOIIW quarterly accounts receivable is $54.50 million, with the most recent change of +$485.00 thousand (+0.90%) on September 30, 2024.
- Over the past year, TOIIW quarterly accounts receivable has dropped by -$4.26 million (-7.25%).
- TOIIW quarterly accounts receivable is now -7.25% below its all-time high of $58.76 million, reached on March 31, 2024.
Performance
TOIIW Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
TOIIW Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +6.4% | -7.3% |
| 3 y3 years | +147.1% | -7.3% |
| 5 y5 years | +189.8% | -7.3% |
TOIIW Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +111.7% | -7.3% | +156.6% |
| 5 y | 5-year | at high | +189.8% | -7.3% | +215.8% |
| alltime | all time | at high | +189.8% | -7.3% | +215.8% |
Oncology Institute Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $54.50 M(+0.9%) |
| Jun 2024 | - | $54.02 M(-8.1%) |
| Mar 2024 | - | $58.76 M(+38.7%) |
| Dec 2023 | $42.36 M(+6.4%) | $42.36 M(-12.6%) |
| Sep 2023 | - | $48.44 M(+5.4%) |
| Mar 2023 | - | $45.96 M(+15.4%) |
| Dec 2022 | $39.82 M | $39.82 M(+14.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $34.82 M(+20.3%) |
| Jun 2022 | - | $28.95 M(+18.1%) |
| Mar 2022 | - | $24.51 M(+15.4%) |
| Dec 2021 | $20.01 M(+16.7%) | $21.24 M(+3.3%) |
| Jun 2021 | - | $20.56 M(+19.1%) |
| Dec 2020 | $17.15 M(+17.3%) | $17.26 M |
| Dec 2019 | $14.62 M | - |
FAQ
- What is Oncology Institute annual accounts receivable?
- What is the all time high annual accounts receivable for Oncology Institute?
- What is Oncology Institute annual accounts receivable year-on-year change?
- What is Oncology Institute quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Oncology Institute?
- What is Oncology Institute quarterly accounts receivable year-on-year change?
What is Oncology Institute annual accounts receivable?
The current annual accounts receivable of TOIIW is $42.36 M
What is the all time high annual accounts receivable for Oncology Institute?
Oncology Institute all-time high annual accounts receivable is $42.36 M
What is Oncology Institute annual accounts receivable year-on-year change?
Over the past year, TOIIW annual accounts receivable has changed by +$2.54 M (+6.39%)
What is Oncology Institute quarterly accounts receivable?
The current quarterly accounts receivable of TOIIW is $54.50 M
What is the all time high quarterly accounts receivable for Oncology Institute?
Oncology Institute all-time high quarterly accounts receivable is $58.76 M
What is Oncology Institute quarterly accounts receivable year-on-year change?
Over the past year, TOIIW quarterly accounts receivable has changed by -$4.26 M (-7.25%)